Price Alert

HUTCHMED (China) Limited (HCM)

NASDAQ: HCM · Real-Time Price · USD

15.89

-0.11 (-0.69%)

At close: Aug 14, 2025, 3:59 PM

15.87

-0.16%

After-hours: Aug 14, 2025, 04:10 PM EDT

-0.69% (1D)

Bid	15.71
Market Cap	2.77B
Revenue (ttm)	630.2M
Net Income (ttm)	37.73M
EPS (ttm)	2.65
PE Ratio (ttm)	6
Forward PE	27.27
Analyst	Strong Buy

Ask	16.35
Volume	33,427
Avg. Volume (20D)	69,175
Open	15.93
Previous Close	16.00
Day's Range	15.80 - 15.97
52-Week Range	11.51 - 21.50
Beta	0.59

About HCM

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol HCM

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for HCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

HUTCHMED (China) has released their quartely earnings on Aug 7, 2025:

Revenue of $277.68M misses estimates by $355.11M, with -9.16% YoY decline.

EPS of 2.61 exceeds estimates by 0.86, with 1640.00% YoY growth.

Next Earnings Release

HUTCHMED (China) Limited is scheduled to release its earnings on Mar 18, 2026, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-9.04%

HUTCHMED shares are trading lower after the compan... Unlock content with Pro Subscription

3 months ago

+12.31%

HUTCHMED shares are trading higher after the company announced it completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric cancer patients with MET amplification.

News

1 week ago · seekingalpha.com

HUTCHMED (China) Limited (HCM) Q2 2025 Earnings Call Transcript

HUTCHMED (China) Limited (NASDAQ:HCM ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Chig Fung Cheng - CFO & Executive Director David Ng - Head of Investor Relations ...

1 month ago · zacks.com

How Much Upside is Left in HUTCHMED (HCM)? Wall Street Analysts Think 73.52%

The average of price targets set by Wall Street analysts indicates a potential upside of 73.5% in HUTCHMED (HCM). While the effectiveness of this highly sought-after metric is questionable, the positi...

1 month ago · seekingalpha.com

Paycom Software: Automating Payroll And HCM Solutions; Initiate With 'Buy'

I am initiating Paycom with a 'buy' rating and a $280 fair value, driven by strong automation-focused HCM solutions. Paycom's innovations like Beti and GONE automate payroll and time-off processes, su...

2 months ago · zacks.com

Wall Street Analysts See a 68.3% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?

The mean of analysts' price targets for HUTCHMED (HCM) points to a 68.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

2 months ago · businesswire.com

Fragmented HCM systems jeopardize business efficiency, Paycom research reveals

OKLAHOMA CITY--(BUSINESS WIRE)--Paycom Software, Inc. (NYSE: PAYC) (“Paycom”), a leading provider of comprehensive, cloud-based human capital management software, discovered surveyed businesses rely o...